拉維達(dá)維韋是一種研究性NS5A抑制劑用于慢性丙型肝炎基因型4的臨床試驗(yàn)。
6-Bromo-2-naphthoic acid
MOC-Val-OH
4-Bromobenzene-1,2-diamine
(S)-1-(tert-Butoxycarbonyl)pyrrolidine-2-carboxylic acid
(S)-tert-Butyl 2-(5-(6-bromonaphthalen-2-yl)-1H-imidazol-2-yl)pyrrolidine-1-carboxylate
Methyl N-[(1S)-1-[[(2S)-2-[5-[6-[2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-2-pyrrolidinyl]-1H-benzimidazol-6-yl]-2-naphthalenyl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]carbamate dihydrochloride
2-Bromo-1-(6-bromonaphthalen-2-yl)ethanone
(S)-tert-Butyl 2-(6-bromo-1H-benzo[d]imidazol-2-yl)pyrrolidine-1-carboxylate
6-Bromo-2-naphthoyl chloride
